154 related articles for article (PubMed ID: 33842835)
1. Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.
Butler W; Huang J
Precis Clin Med; 2021 Mar; 4(1):25-34. PubMed ID: 33842835
[TBL] [Abstract][Full Text] [Related]
2. Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases.
Waldum H; Slupphaug G
Front Oncol; 2024; 14():1369907. PubMed ID: 38660133
[TBL] [Abstract][Full Text] [Related]
3. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy.
Feng DC; Zhu WZ; Wang J; Li DX; Shi X; Xiong Q; You J; Han P; Qiu S; Wei Q; Yang L
Mil Med Res; 2024 Apr; 11(1):21. PubMed ID: 38605399
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Stem Cells: Biology and Treatment Implications.
Koukourakis IM; Platoni K; Kouloulias V; Arelaki S; Zygogianni A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834336
[TBL] [Abstract][Full Text] [Related]
5. ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers.
Park S; Das R; Nhiem NX; Jeong SB; Kim M; Kim D; Oh HI; Cho SH; Kwon OB; Choi JH; Park CS; Kim SR; Moon UY; Cha B; Choi DK; Lee S; Namkung W; Woo J; Seo Y
Front Pharmacol; 2023; 14():1163970. PubMed ID: 37274097
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application.
Megerian MF; Kim JS; Badreddine J; Hong SH; Ponsky LE; Shin JI; Ghayda RA
Aging Dis; 2023 Jun; 14(3):840-857. PubMed ID: 37191417
[TBL] [Abstract][Full Text] [Related]
7. Basal epithelial cells in prostate development, tumorigenesis, and cancer progression.
Pitzen SP; Dehm SM
Cell Cycle; 2023 Jun; 22(11):1303-1318. PubMed ID: 37098827
[TBL] [Abstract][Full Text] [Related]
8. Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.
Butler W; McDowell C; Yang Q; He Y; Zhao Y; Hauck JS; Zhou Y; Zhang H; Armstrong AJ; George DJ; Drake R; Huang J
NPJ Precis Oncol; 2023 Feb; 7(1):22. PubMed ID: 36828904
[TBL] [Abstract][Full Text] [Related]
9. Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
Butler W; Xu L; Zhou Y; Cheng Q; Hauck JS; He Y; Marek R; Hartman Z; Cheng L; Yang Q; Wang ME; Chen M; Zhang H; Armstrong AJ; Huang J
J Pathol; 2023 May; 260(1):43-55. PubMed ID: 36752189
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and paracrine characteristics of neuroendocrine prostate cancer.
Arman T; Nelson PS
Front Endocrinol (Lausanne); 2022; 13():1012005. PubMed ID: 36440195
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation.
Asberry AM; Liu S; Nam HS; Deng X; Wan J; Hu CD
Comput Struct Biotechnol J; 2022; 20():5873-5885. PubMed ID: 36382181
[TBL] [Abstract][Full Text] [Related]
13. A rare case of prostate neuroendocrine tumor: A case report.
Teh S; Inn FX; Rizuana IH; Wm WM
Front Oncol; 2022; 12():1009146. PubMed ID: 36263212
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythm in prostate cancer: time to take notice of the clock.
Zhu WZ; He QY; Feng DC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):184-191. PubMed ID: 36073562
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance.
Islam R; Mishra J; Polavaram NS; Bhattacharya S; Hong Z; Bodas S; Sharma S; Bouska A; Gilbreath T; Said AM; Smith LM; Teply BA; Muders MH; Batra SK; Datta K; Dutta S
Cell Rep; 2022 Jul; 40(3):111097. PubMed ID: 35858551
[TBL] [Abstract][Full Text] [Related]
16. Role of prostate cancer stem-like cells in the development of antiandrogen resistance.
Kushwaha PP; Verma S; Kumar S; Gupta S
Cancer Drug Resist; 2022; 5(2):459-471. PubMed ID: 35800367
[TBL] [Abstract][Full Text] [Related]
17. Imaging of neuroendocrine neoplasms of the male GU tract.
Sharbidre KG; Morani AC; Zahid M; Bhosale P; Lall C; Francis IR; Verma S
Abdom Radiol (NY); 2022 Dec; 47(12):4042-4057. PubMed ID: 35412112
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted Effects of Lycopene: A Boulevard to the Multitarget-Based Treatment for Cancer.
Marzocco S; Singla RK; Capasso A
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500768
[TBL] [Abstract][Full Text] [Related]
19. Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy.
Khoobchandani M; Khan A; Katti KK; Thipe VC; Al-Yasiri AY; MohanDoss DKD; Nicholl MB; Lugão AB; Hans CP; Katti KV
Sci Rep; 2021 Aug; 11(1):16797. PubMed ID: 34408231
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
